Menu
Home >> Introduction

Introduction


National
Institute of Pharmaceutical Education & Research (NIPER)


Indian Pharma Industry has been a global leader in Generic drugs. In order to acquire leadership position in drug discovery and development and to continue to excel in the formulations, Government
recognized that human resources/talent pool is very critical. Thus Government of India has set up National Institute of Pharmaceutical Education & Research (NIPER) at SAS Nagar Mohali as a registered society
under the Society Registered Act 1860, Subsequently the Institute was given statutory recognition by an act of Parliament NIPER Act, 1998 and the Institute

declared as an Institute of National Importance.

During 2007-08, six new NIPERs were started at Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli with the help of Mentor
Institute. Subsequently a NIPER at Madurai was approved in 2012. During 2015-16 the Finance Minister in his Budget Speech announced 3 new NIPERs for the states
of Chhattisgarh, Maharashtra and Rajasthan.

 


NIPER


Mentor Institute


Academic Session

NIPER,
Mohali

-

1998

NIPER,
Ahmedabad

-

2007

NIPER,
Guwahati


Guwahati Medical College, Guwahati

2008

NIPER,
Hajipur


Rajendra Memorial Research Institute of Medical Science (RMRIMS-Patna)
under ICMR

2007

NIPER,
Hyderabad

CSIR-Indian
Institute of Chemical Technology, Tarnaka, Hyderabad

2007

NIPER,
Kolkata

CSIR-Indian
Institute of Chemical Biology, Kolkata

2007

NIPER,
Raebareli

CDIR-Central
Drug Research Institute, Lukhnow

2008

NIPER,
Madurai

Under
Process

-

NIPER,
Chhattisgarh

Under
Process

 

NIPER,
Maharashtra

Under
Process

-

NIPER,
Rajasthan

Under
Process

-



 



The main objectives of NIPER are as under:-

·        

Nurture and promote quality and excellence in pharmaceutical education and

research:

·        

Run Master's, Doctoral and post-Doctoral

courses and research in pharmaceutical education;

·        

Develop a multi-disciplinary approach in carrying out research and training
of

pharmaceutical manpower ; and

·        

Act as nucleus for interaction between academic and industry by

undertaking sponsored and funded research as well as

consultancy projects

 Admission Procedure in NIPERs:The students are selected for admission through All India Common Admission
Test conducted by NIPERs, At present these NIPERs impart Ph.D and PG level
education and grant degree under the NIPER Act, 1998.


1. NIPER -
MOHALI


NIPER, SAS Nagar, Mohali was initially registered as a society under the
Societies Act. The faculty for the institute was appointed in 1994. In 1998,
Parliament enacted National Institute of Pharmaceutical Education and
Research Act, 1998. NIPER was declared as an “Institute of National
Importance” under the Act of Parliament on 26th June 1998. NIPER
is a member of Association of Indian Universities.


 



Disciplines:
The first batch of students was admitted in 1998. NIPER offers Masters’
and Ph.D. degrees in 15 streams and caters to the various needs of
pharmaceutical industry:


1.           
Medicinal Chemistry

2.           
Natural Products

3.           
Traditional Medicine

4.           
Pharmaceutical Analysis

5.           
Pharmacology & Toxicology

6.           
Regulatory Toxicology

7.           
Pharmaceutical Technology (Biotechnology)

8.           
Pharmaceutical Technology (Formulations)

9.           
Pharmaceutical Technology (Process Chemistry)

10.        
Pharmaceutics

11.        
Biotechnology

12.        
Pharmacy Practice

13.        
Clinical Research

14.        
Pharmacoinformatics

15.        
Pharmaceutical Management



Student’s details: 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


247


255


Ph. D.


33


22



Total



280



277


 


 
Academic excellence:
 In 2017, the Institute has published 63 articles in journals of repute (till
Oct. 2017). NIPER has filed 4 patents in 2017-2018 (till Oct. 31, 2017) and
56 patents have been granted till date.  Since the inception of academic
programme (till Nov. 1, 2017), 2968 students have passed out (Masters 2169,
MBA 529 & Ph.D. 270). 



Teacher-Student ratio:-
 



Course



Ratio


Ph.D.


(S-120:F27) i.e 4.4:1


Masters’ (Science)


416:27


MBA (Pharm.)


78:3


*

Guest faculty members are also taking classes



 Research:-



 
       

   
A. Neglected diseases -


Research is carried out in the areas of tuberculosis, leishmaniasis and
malaria. New molecules are being synthesized and their mechanisms of action
are being worked out.



B. Other diseases


Metabolic pathways in diseases like inflammation, infection, cancer,
diabetes, neurodegeneration are being worked out.



C. Drug development and formulation


i.    Improvement of oral bioavailability, synergistic anticancer efficacy
and reduced toxicity of drugs has been attempted.

ii.   

New formulations are being developed.

 


D. Other areas

  1. Chemo-enzymatic synthesis of drugs
  2. Monograph on
    herbals is being developed.
  3. Study of the effect of RNA aptamers on stabilization of misfolded
    proteins
  4. Assessment of an appropriate and reliable method to diagnose neuropathic
    pain


 Innovation / knowledge transfer



                    
     
i.       

Patents and Commercialisation
:
183 (filed)/56 (granted)/08 (licensed)



                    
    
ii.     

Research income earned from industry: Rs.20 lakh (receipts in 2017-18 till
date)

            
iii.  Citation per faculty: 798 (2016 till date)

 



Institution leadership


              
i.               

Ranked #1 in the category ‘Pharmacy’ in NIRF MHRD 2018 Rankings


           
ii.               

Recognized as
among the top 100 Indian Innovator companies and research organizations
(2014) (Thompson Reuters)


          
iii.               

Recognized as one of the four institutes in the country with AAAA+ ranking
by Career360 magazine (Outlook group) (March 2014)


          
iv.               

Chosen as one
of the destinations (apart from USA and UK) by Government of Kazakhstan for
award of Bolashak scholarship to its nationals to pursue research
programme in pharmaceutical sciences


 



Impact of NIPER

The success of NIPER, S.A.S. Nagar has encouraged the GoI to set up more
NIPERs across the country to meet the growing demands of the pharmaceutical
sector. In addition, NIPER has carried out training programmes for personnel
from India and abroad under ITEC-SCAAAP, capacity building programmes (World
Bank-sponsored) and SMPIC. Participation in rebuilding of public sector
enterprises like IDPL, BCPL, HAL, etc. Training and analytical services
provided to small and medium-scale enterprises (SMEs): Setting up of a
centre for SMEs. Member of committee evaluating ‘Investigational New Drugs’
(IND) applications.


 


  

2.   

NIPER-
Ahmedabad



 
NIPER
Ahmedabad was established in the year 2007. Since its inception, the
institute was   functioning under Mentor Institute B.V. Patel PERD Centre up
to 31st July 2016.  From 01st August, 2016 it has started functioning
independently at its own campus at Palaj, Gandhinagar in temporary building
with a state of art research laboratory facility including animal house. In
absence of Board of Governors, Steering Committee under the Chairmanship of
Secretary (Pharma), Department of Pharmaceuticals, looks after
administrative work in NIPER Ahmedabad.

 



Discliplnes:
NIPER offers Masters’ and Ph.D. degrees in 7 streams and
caters to the various needs of pharmaceutical industry:


 


1. Natural Products


2. Pharmaceutics


3. Biotechnology


4.
Medicinal Chemistry


5.
Pharmaceutical Analysis


6.
Pharmacology and Toxicology


7.
Medical Device


 



Students detail:



 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


72


70


Ph. D.


13


01



Total



85



71


 

 Academic
excellence

 NIPER
Ahmedabad has a total of 405 M.S Pharm. students already graduated from
NIPER- Ahmedabad and are well placed in various Pharma industries in India
and abroad.     Presently, 72 students are pursuing their M.S.(Pharm) course
in different disciplines. A total of 29 students are continuing with their
PhD studies, o3 students have already submitted their PhD thesis and 03
students have been awarded Ph.D. Degree. Institute has filed up till now 10
patents wherein faculty or students of NIPER-Ahmedabad are one inventors.

 


Teacher-Student ratio:
    
Presently 1: 9 (19 Faculty : 170 students)

 

Research:

 a. Active
Research Areas:
Diabetes, Cancer,

Neurodegenerative Disease, Infectious
diseases, Tissue repair, regeneration and
Medical Implants.

b.
Projects:
   Completed : 05   Ongoing:12 (09 –National , 03 – International)



c. Publications:
    89 Total,
29 (Year 2017)

d. Poster
Presentations:
    55 (Year
2017)
  

 


 Innovation & Knowledge transfer

  03 Patent
has been filed from Feb 2016 onwards.

  

Impact of
NIPER :

 NIPER
Ahmedabad would serve as a good launching platform to revamp the pharma
education and research, to initiate the new era of pharmaceutical and
biomedical sciences. NIPER-Ahmedabad lays its commitment in building human
resource for promoting research and development in the country and
contribute towards ‘’Make in India’’ initiative as a part of its
national responsibility

3.   

NIPER
Guwahati


 
NIPER
Guwahati started functioning from 2008 under Mentor Institute


Guwahati Medical College Guwahati, Assam

(up to 31 July 2017). In the absence of Board of Governors, Steering
Committee under the Chairmanship of Secretary (DoP, Govt. of India) look
after administrative work in NIPER Guwahati. From 1st August
2017, NIPER-Guwahati is functioning from the NITS-Mirza Campus.

 Disciplines: NIPER offers Masters’ and Ph.D. degrees in 3 streams and
caters to the various needs of pharmaceutical industry:
 

1.

Pharmacology & Toxicology


2. Pharmacy Practice


3. Biotechnology.
 



Students detail:
 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


39


39


Ph. D.


04


Pursuing



Total



43



39


 
 

Academic
excellence:



     

    



 
i.       

Ph.Ds– 25
(enrolled), Degrees awarded – 08



   
ii.       
Total M.S. (Pharm.) (since inception),

Students
enrolled – 324

 iii.   
Graduated -
248 (74 students are currently pursuing their P.G. courses)



  
iii.       


Among the graduated students, many of them got admission into Ph.D. programs
in various National & International Universities/Institutes. Rest of the
students got placed in various Pharmaceutical Industries and Consultancies
viz., Novartis, Novo Nordisk, Biocon, Quintilles, etc.



   


  


iv.       
Publications: In total, 112 research papers have been published out
of which 20 articles have been published in the current year in various
National and International Journals. 



Teacher-Student ratio:
 


 Biotechnology                                :1:10


 Pharmacology and Toxicology     : 1:20


 Pharmacy Practice                        :1:10


 



Research:

 BIOTECHNOLOGY : Development
of Biopharmaceuticals using Biomolecular Engineering/Synthetic Biology
approaches -

v 

Oncogenic
mRNA cleaving Deoxyribozymes;

v 

Development
of new approaches of Immune rerouting for targeting cancer cells;

v 

Riboswitch
mediated gene regulation of oncogenes;

v 

Generation of
random Protein coding sequences & Aptamer based therapeutics and diagnostic
tools.

 

Investigation
on Genomics and Proteomics to study various diseases like Multiple
Myeloma, Acute Myeloid leukemia, Chronic Myeloid leukemia, Myodisplastic
syndrome, Ischemia-Stroke disorder, Neuropathic Pain, etc.

 

PHARMACOLOGY AND TOXICOLOGY: 

v 

Molecular
Pharmacology;

v 

Development
of Cancer targeted drug delivery systems;

v 

Screening
Indian biodiversity and Indian Systems of Medicine in search of newer
compounds in the area of inflammation, arthritis, diabetes, cancer and
hepatoprotective activities;

v 

Targeting
RANKL for the treatment of inflammation and cancer induced bone disorders.

v 

Screening of
NCE’s & North-East plant products for anti-Parkinson’s and antidepressant
effects.

v 

Studies on
the mitigation of drug induced toxicities through natural products derived
from Northeast
India.

   

   
PHARMACY
PRACTICE:

v 

Study of drug
utilization pattern for antiepileptic and antipsychotic drugs.

v 

Impact of
Lipodystrophy on Quality of Life, Social and Psychological Aspects in PLHIV
on First line and Second line Anti Retroviral regimen

v 


Haemovigilance:  


A
n
important tool for improving safe blood transfusion practices

 

 Innovation & Knowledge transfer:The institute is currently in the process of submitting one patent
application in the area of Biopharmaceuticals. It will be further explored
for its commercial value.

 Impact of NIPER: The establishment of NIPER-Guwahati has given a strong boost to the
promotion of Pharmaceutical Education & Research in the North East region of
India. Research efforts of NIPER Guwahati have revived the studies on
medicinal value of local herbs of North East Region against various
diseases. NIPER-Guwahati is further moving ahead in the field of
Biopharmaceuticals and is the only NIPER to have a Synthetic Biology
Laboratory, which is listed among the Indian Synthetic Biology labs.


 
 

4.   

NIPER Hajipur 

NIPER Hajipur
started functioning in 2007 under Mentor Institute


Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna.

In absence of Board of Governors, Steering Committee under the Chairmanship
of Secretary (Pharma) looks after administrative work in NIPER Hajipur.

 Disciplines: NIPER offers Masters’ and Ph.D. degrees in 3 streams and
caters to the various needs of pharmaceutical industry:


1. Biotechnology


2. Pharmacy  Practice


3. Pharmacoinformatics


 



Students detail: 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


36


22


Ph. D.


06


Pursuing



Total



42



22



 
 

Academic
excellence:
-
 

NIPER Hajipur
has awarded


286 students


their Master’s degree since its inception. 



Teacher-Student ratio:
          
1:10


 



Research


Biotechnology

  • Development of novel drugs against Kala zaar (Leishmaniasis) targeting
    epigenetic factors and DNA repair pathway.

  • Development of non-invasive tool for early detection of breast cancer

  • Development of Novel therapeutic strategies against HIV

  • Application of functionalized and conjugated gold Nanoparticles for improved
    antimicrobial efficacy

  • Pharmacoinformatics

  •  Identification of novel inhibitors for cysteine synthase enzyme for
    Leishmania donovani
    . Using structure based pharmacophore models,
    Molecular dynamics studies and virtual screening methods.

  • Development of novel inhibitors for G-Protein Coupled Receptor 3(GPR3)  for
    the treatment of  Alzheimer's disease (AD) using QM docking studies,
    homology modelling, molecular dynamics (MD) studies, free energy calculation
    studies.


 
Pharmacy Practice

·        

HPV and associated clinical outcomes in cervical cancer

·        

Association among periostin, testosterone and obesity with the incidence of
osteoporosis in elderly male type 2 diabetic patients

·        

Assessment of sex hormones (estrogen and testosterone) in type 2 diabetes
mellitus patients under oral hypoglycemic drugs

·        

 Assessment of periostin in post menopausal thyroid patients and finding
relationship with osteoporosis

·        

To evaluate the ADR of imatinib with reference to p210 and p190 fusion
transcripts in chronic myloidleukemia patients.


 
Impact of NIPER:


 


NIPER Hajipur has successfully produced 286 students in three disciplines
namely, Biotechnology, Pharmacoinformatics and Pharmacy Practice who are
either employed in different pharmaceutical industries or pursuing their
higher education in different institutes or universities across the globe.
Many of NIPER Hajipur ex-students are engaged as faculty at different
institutions.   

5.   

NIPER
Hyderabad
 

 NIPER
Hyderabad started functioning in 2007 under Mentorship of Institute


Indian Institute of Chemical Technology, CSIR-IICT, Hyderabad.

In absence of Board of Governors, Steering Committee under the Chairmanship
of Secretary (Pharma) look after administrative work in NIPER, Hyderabad.

 Disciplines: NIPER offers Masters’ and Ph.D. degrees in 7 streams and
caters to the various needs of pharmaceutical industry:

1.

Medicinal Chemistry

2. Pharmaceutical Analysis

3. Pharmacology & Toxicology

4. Pharmaceutics

5.Pharmaceutical Management

6. Pharmaceutical Technology (Process Chemistry)

7. Regulatory Toxicology


 
Students detail: 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


121


112


Ph. D.


20


8



Total



141



120



 
Academic
excellence
:-


 

           
Master Students Passed Out                     : 707

             


Students pursuing Ph.D course               : 79


              Doctoral degree awarded                           : 22


              Patents (filed)                                              
: 12


              Research Publications                               : 450


            Sanctioned extramural research projects            : 29


 


Teacher-Student ratio


 


Faculty: Student ratio should be 1:10, but few departments are having 1:15
ratio.


 



Core Research areas:

v

Integrated
Drug Discovery & Product Development  Programmes

     a)
Cancer, Inflammation and related proliferative diseases

     b)
Diabetes and other metabolic disorders

     c)
Infectious diseases

     d)
Psoriasis

v

In vitro
and
in vivo screening

v

Development
of novel Process for NCEs, Bulk Drugs and Intermediates

v

Development
of Analytical Methods, Impurity Profiling and Stability studies

v

Solid state
characterization
                         

Innovation
/ knowledge transfer


 


(i) Patents and commercialization- 12 patents filed

in areas of
Cancer Drug Discovery,

    
Formulation Development and Analytical Method Development

(ii) Research
income earned from Industry – 22 Lakhs

(iii)
Citation per faculty- Average 320 citations per faculty

 



 Impact of NIPER
:

Creating
excellent human resource by imparting high quality education and training in
pharmaceutical sciences which would help the pharmaceutical industry.
Serving as an excellent research institute by focusing on thrust areas of
national and international relevance. Fostering academic and industrial
collaborations to address some of the key issues in the pharma sector and
producing pharma productive human resource professionals to cater to the
needs of Pharmaceutical industry in the country.
 



 



6.   


NIPER Kolkata
 


NIPER, Kolkata is presently housed at the Indian Institute of Chemical
Biology (IICB) – a premier Institute of the Council of Scientific &
Industrial Research (CDRI), India, which is the Mentor Institute. In absence
of Board of Governors, Steering Committee under the Chairmanship of
Secretary (Pharma) looks after the administrative work of the institute.


 



Disciplines
:


 


NIPER offers Masters’ and Ph.D. degrees in 3 streams and
caters to the various needs of pharmaceutical industry:
 


1.


Medicinal Chemistry


2. Natural Products


3. Phamacoinformatics


 
Students detail: 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


44


44


Ph. D.


10


pursuing



Total



54



44


  
Academic
excellence
:
 Since
inception till date 364 students have been graduated. Among them, 247 have
been engaged in different companies and academic institutions. Institute is
not aware of any unemployed among NIPER-K graduates.
 



Teacher-Student ratio: 1:11


 
Research:



a.   
Active Research Areas
:
Synthetic and plant based drug discovery, immunology and immune diagnostics,

cellular and molecular biology,
recombinant DNA technology and monoclonal antibody technology, novel drug
delivery systems, chemical and biochemical process technology, etc.



b.   
Innovation & Knowledge transfer
:
93 Nos. Research papers have been
published in renowned international journals from the project work of the MS
(Pharm.) students. 

 



Impact of NIPER:

  • A total of 364 highly
    knowledged students have been graduated.

  • 247 students are
    engaged to work in companies/institutions.

  • 35 Research papers have
    been published.


  • 3 numbers of MS (Pharm.) second year students have undergone their project
    work in M/s Sanofi India Pvt. Limited. During their 3 months training
    monthly stipend were paid by the M/s Sanofi India Pvt. Ltd.

  • M.S. (Pharm.) students of NIPER-Kolkata

    stood 1st & 2nd
    position in the National
    Eligibility Test for Ph.D. course admission conducted by NIPER-Mohali
    continuously two years 2016-17 & 2017-18


Central
Drug Research Institute, Lucknow.
In absence of
Board of Governors Steering Committee under the Chairmanship of Secretary
(Department of Pharmaceuticals) look after administrative work of
NIPER-Raebareli. 


Disciplines:

 


NIPER offers Masters’ and Ph.D. degrees in 3 streams and
caters to the various needs of pharmaceutical industry:
 

1.

Medicinal Chemistry


2. Pharmaceutics


3. Pharmacology and Toxicology.


 



Students detail:
 



2017-2018



Course



Enrolled



Pass-out


M.S (Pharm)


37


37


Ph. D.


06


pursuing



Total



43



37


 

 Academic
excellence:-.
 

       (i)
Total 258 passed out since inception of the institute.

             
(ii) 

Ph.D. programme in three disciplines viz. Medicinal Chemistry, Pharmaceutics
and Pharmacology and Toxicology have been started from academic session
2017-18 in order to boost R&D activities in pharmaceutical sciences.

            (iii)  Among the graduated students, many of them got selected
in various Pharma industries and others have got admission in Ph.D. programs
in various National & International Universities/ Institutes.

            (iv) More than 40 papers have been published in various reputed
National and International Journals.
 


Teacher-Student ratio      


         Course


Ratio

Ph.D.

1:1

M.S.
(Pharm.)

1: 15

 

Research - 

The various R & D activities currently in progress and/or planned at NIPER,
Raebareli are as follows-

·

Design and development of drugs/drug intermediate for the treatment of
inflammatory and oxidative stress.

·

Study of bioavailability related issues and for site specific/targeted drug
delivery.

·

Development and evaluation of drugs/formulations for heavy metal toxicity
like arsenic.

·

Safety studies of nanoparticle based materials like, metallic gold, zinc,
copper etc


 

Impact of
NIPER

·               

Created
excellent human resource by imparting high quality education in
pharmaceutical sciences.

·               

Served as an
excellent research institute by focusing on thrust areas of national and
international relevance.

·               


Faculty have published research papers and reviews and also chapters in
books in highly rated journals and international publications like Elsevier/
Springer etc.

 National Institute of Pharmaceuticals Education and Research (NIPERs)
Contact List



S. No.



Responsibility Centers and Subordinate



Landline Number



Email



Mobile Number



Address


1.


Prof. A. Raghuram Rao Director)


0172-2214690


0172-2214697


director[at]niper[dot]ac[dot]in


08790432456


SAS Nagar, NIPER Mohali,


Punjab - 160062


 


2.


Dr. Kiran Kalia, (Director)


 


079-66745555


kirankalia[at]gmail[dot]com


 


9714618573


Palaj Opp. Air Force Station Head Quarter, Gandhinagar-382355,
Gujarat.


 


3.


Dr. Shashi Bala Singh


(Director)


040-23073740


director[dot]niperhyd[at]gov[dot]in


09999297992


NIPER, Hyderabad IDPL Township, Balangar, Hyderabad-500007


4.


Dr. Pradeep Das, (Project Director)


0612-2631565


drpradeep[dot]das[at]gmail[dot]com


09431012380


E.P.I.P. Campus, Industrial Area,



 


5.


Dr.V. Ravichandiran, (Director)


033-24995803


033-23200086


vishnuvardhr[at]gmail[dot]com director[at]niperkolkata[dot]edu[dot]in


09443963481


Indian Institute of Chemical Biology (IICB, under CSIR),


Mentor Institute for NIPER-Kolkata


4, Raja S.C. Mullick Road,


Jadavpur, KOLKATA-700 032 (W.B.)


6.


Dr. USN Murty (Director)


0361-2132751




murtyusn[at]gmail[dot]com


murty_usn[at]yahoo[dot]com


0912706998


C/o NITS-Mirza


Santipur, Parlli Part, NH-37


Mirza, Kamrup, Assam - 781 125


 


7.


Dr. SJS Flora (Director)


0535-2700851


sjsflora[at]hotmail[dot]com


09425482305


Shree Bhawani Paper Mill Road, ITI compound, Raebareli U.P. – 229010